Syneron Medical Ltd. (ELOS) 7.06 $ELOS
Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
PR Newswire - Thu May 19, 6:00AM CDT
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended March 31, 2016.
ELOS: 7.06 (-0.18)
Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016
PR Newswire - Wed Apr 27, 8:00AM CDT
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, May 19, 2016. The earnings release will be available on Syneron's website at www.investors.syneron.com.
ELOS: 7.06 (-0.18)
Syneron Candela Leads Energy Innovation Discussions at 36th Annual ASLMS Conference
PR Newswire - Thu Mar 31, 8:00AM CDT
Syneron Medical Ltd. (NASDAQ: ELOS) a global leader in aesthetic medical devices, today announced the presentation of 11 scientific abstracts at the Annual Conference of the American Society of Laser Medicine and Surgery (ASLMS). During the conference, industry luminaries will present new and breakthrough findings demonstrating safety and efficacy from clinical studies using Syneron Candela technologies for treating skin pigmentations, removing tattoos, removing hair and restoring vaginal health. The 36th annual conference will take place March 30 through April 3, 2016 at the Sheraton Boston Hotel/Hynes Convention Center in Boston, Mass.
ELOS: 7.06 (-0.18)
Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website
PR Newswire - Mon Mar 21, 3:05PM CDT
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F, containing audited consolidated financial statements for the year ended December 31, 2015, as filed with the Securities and Exchange Commission on March 21, 2016, is available on its website (www.syneron.com). Shareholders may receive a hard copy of the annual report free of charge upon request. This press release is being issued pursuant to NASDAQ Listing Rule 5250(d)(1)(C).
ELOS: 7.06 (-0.18)
Syneron Medical and Allergan Announce U.S. Aesthetics Collaboration
PR Newswire - Sat Mar 05, 1:13PM CST
Syneron Medical Ltd. (NASDAQ: ELOS) a leading global aesthetic device company, and Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, today announced a collaboration to offer three of Syneron Candela's body sculpting and skincare platforms to members of Allergan's healthcare provider loyalty program, Allergan Partner Privileges® (APP®).
AGN: 240.93 (-6.47), ELOS: 7.06 (-0.18)
Global Beauty Devices Market Growth of 18.9% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: L'Oreal Group, Carol Cole Company & Panasonic Corporation
M2 - Fri Feb 05, 8:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/27r9hf/global_beauty) has announced the addition of the "Global Beauty Devices Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type and by Application" report to their offering. The global beauty devices market accounted for $19,716.9 million during 2014, and it is expected to grow with a CAGR of 18.9% during 2015-2020. The Hair removal devices market segment dominated the market during 2014 with about 21.4% share; whereas, among application segment, salon accounted for the highest share of about 55.6% in market during the same year. Beauty devices market is escalating with high growth rate due to growing geriatric population and increasing prevalence of skin diseases as a result of harmful UV radiations. Also, increase in disposable income in developing lead to increased spending on personal care products. Key Topics Covered: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market - Porter analysis identifies competitive forces within the market Companies Mentioned: - Carol Cole Company - Home Skinovations, Ltd - Koninklijke Philips N.V. - L'Oreal Group - Nu Skin Enterprises, Inc. - Panasonic Corporation - PhotoMedex, Inc. - Procter & Gamble Company - Syneron Medical, Ltd. - TRIA Beauty, Inc. Report Structure: 1. Research Scope and Methodology 2. Executive Summary 3. Market Outlook 4. Global Beauty Devices Market Size and Forecast (2011 - 2020) 5. Global Beauty Devices Market Breakdown by Type of Devices 6. Global Beauty Devices Market Breakdown by Application 7. Global Beauty Devices Market Breakdown by Geography 8. Competitive Analysis 9. Company Profiles 10. Appendix For more information visit http://www.researchandmarkets.com/research/27...bal_beauty
ELOS: 7.06 (-0.18), NUS: 41.37 (-0.48), PHMD: 0.23 (-0.02), PG: 83.20 (+0.03)
Syneron Medical to Report Fourth Quarter 2015 and Full Year 2015 Financial Results on February 22, 2016
PR Newswire - Wed Feb 03, 3:01PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2015 and full year 2015 financial results before the market opens on Monday, February 22, 2016. The earnings release will be available on Syneron's website at www.investors.syneron.com.
ELOS: 7.06 (-0.18)
Medical Aesthetics Market Forecast to 2020 - Increasing Demand For Minimally Invasive & Non-Invasive Aesthetic Procedures
M2 - Thu Jan 28, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/bd5l42/medical) has announced the addition of the "Medical Aesthetics Market by Products, Procedures, & End-Users - Global Forecast to 2020" report to their offering. The market is expected to reach $12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020. Factors such as the increasing demand of minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. However, stringent safety regulations for aesthetic procedures, and a significant number of product recalls are restricting the growth of the global medical aesthetics market. Geographically, North America (comprising the U.S. and Canada) commanded the largest share of 49.0% of the global medical aesthetics market in 2015, followed by Europe. North America will continue to lead in the years to come, owing to rapidly aging and obese population, technological advancements, and growing FDA approvals of devices in the U.S. The growth of the global medical aesthetics market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, aging population, increasing awareness among customers, technological advancements in energy-based devices, rising number of aesthetic procedures, and increasing demand for aesthetic treatments among the male population. However, a stringent safety regulation for aesthetic procedures is a major factor restraining the growth of this market. Growing adoption of home use aesthetic devices and increasing demand for cosmetic treatments in emerging markets are creating opportunities for growth of the medical aesthetics market. Companies Mentioned: - Allergan, Inc. - Cynosure, Inc. - Galderma S.A. (Switzerland) - Lumenis Ltd. - Mentor Worldwide LLC - PhotoMedex, Inc. - Solta Medical, Inc. - Syneron Medical, Ltd. - ZELTIQ Aesthetics, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Market, By Product 7 Medical Aesthetics Market, By End User 8 Medical Aesthetics Market, By Procedure 9 Global Medical Aesthetics Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/bd5l42/medical
ELOS: 7.06 (-0.18), AGN: 240.93 (-6.47), ZLTQ: 28.51 (-0.85), CYNO: 51.02 (-1.06), LMNS: 13.76 (+0.04), PHMD: 0.23 (-0.02)
BUYINS.NET: ELOS, PGJ, SMMU, ACW, VIA, MOBI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jan 26, 8:00AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Syneron Medical Ltd (NASDAQ:ELOS), PowerShares Golden Dragon Halter USX China Portfolio (NYSE
GJ), PIMCO Short Term Municipal Bond Strategy Fund (NYSE:SMMU), Accuride Corp (NYSE:ACW), Viacom Inc (NASDAQ:VIA), Sky-mobi Ltd (NASDAQ:MOBI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ELOS: 7.06 (-0.18), VIA: 46.22 (-2.20), ACW: 1.56 (-0.05), PGJ: 27.84 (-0.74), MOBI: 1.81 (-0.03), VIAB: 42.02 (-2.39), SMMU: 50.53 (+0.14)
Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue
PR Newswire - Mon Jan 11, 3:05PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today provided preliminary unaudited fourth quarter 2015 revenue results in conjunction with planned meetings January 11-14 surrounding the annual J.P. Morgan Healthcare Conference in San Francisco. Total revenue for the fourth quarter 2015 is expected to be in the range of $78 to $79 million, compared to $74.1 million in the fourth quarter 2014, up approximately 5% to 7% year-over-year, or approximately 9% to 10% in constant currency.
ELOS: 7.06 (-0.18), JPM: 63.84 (-0.91)
Profound Named 2015 Beauty Breakthrough
PR Newswire - Wed Dec 23, 9:22AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, is proud to announce that its revolutionary Profound® non-surgical radiofrequency micro-needle device with proprietary and patent protected technology, has been hailed one of 2015's biggest aesthetic breakthroughs by Yahoo! Beauty and Plastic Surgery Practice Magazine.
ELOS: 7.06 (-0.18)
Dental Lasers Market - Global Forecast to 2020
M2 - Fri Dec 04, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/xckzhj/dental_lasers) has announced the addition of the "Dental Lasers Market - Global Forecast to 2020" report to their offering. The global dental lasers market is expected to reach USD 224.7 million by 2020, at a CAGR of 5.2% during the forecast period from 2015 to 2020. The increasing awareness for oral hygiene; rising middle class and aging population; and rising demand for cosmetic dentistry, reduced treatment time, and operating cost have influenced the growth of the dental lasers market. The soft tissue dental lasers segment accounted for the largest share of the global dental lasers market in 2014. Soft tissue lasers are used to sterilize endodontic canals and treat periodontal disease as well as in tooth whitening procedures. The soft tissue dental laser segment dominated the market, owing to the increased number of cases of gingivectomy and periodontal diseases, among others. North America dominated the dental lasers market, due to the increasing technological advancements, growing awareness with respect to oral hygiene, and rising adoption rate of newer technologies in the region. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, due to factors such as the rise in the awareness of dental lasers, increased number aesthetic procedures, and rise in aging population. Reasons to Buy the Report: From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Industry Trends 5 Market Overview 6 Dental Lasers Market, By Product 7 Dental Lasers Market, By Application 8 Dental Lasers Market, By End User 9 Dental Lasers Market, By Geography 10 Competitive Landscape 11 Company Profiles - AMD Lasers - Biolase, Inc. - CAO Group, Inc. - Convergent Dental, Inc. - Danaher Corporation- Kavo Dental Gmbh - Fotona D.D. - Ivoclar Vivadent AG - Millennium Dental Technologies, Inc. - Sirona Dental Systems, Inc. - Syneron Dental Lasers-Syneron Medical Ltd. - The Yoshida Dental Mfg. Co., Ltd. - Zolar Technology & Mfg. Co. Inc. For more information visit http://www.researchandmarkets.com/research/xc...tal_lasers
ELOS: 7.06 (-0.18), SIRO: 109.97 (-0.13), BIOL: 1.22 (+0.05), DHR: 99.31 (-1.08)
Syneron to Host 2015 Analyst Day on December 3, 2015
PR Newswire - Tue Dec 01, 8:00AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an Analyst Day meeting on Thursday, December 3, 2015 from 8:30 am to 11:30 am ET (registration begins at 8:30 am, formal presentation begins at 9:00 am). The meeting will include a review of the Company's key growth platforms, including UltraShape, PicoWay, and Profound and will feature presentations from management and clinician key opinion leaders.
ELOS: 7.06 (-0.18)
Analyst Insights behind Price Movement - Research on Lipocine, Syneron Medical, Republic Airways and Accretive Health
ACCESSWIRE - Tue Nov 24, 7:32AM CST
NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc (NASDAQ: LPCN), Syneron Medical Ltd. (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health, Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.06 (-0.18), RJET: 1.31 (+0.02), LPCN: 8.16 (-0.94)
Origins of Technical Movement, Pricing Tomorrow - Research on Lipocine, Syneron Medical, Republic Airways Holdings, and Accretive Health
ACCESSWIRE - Mon Nov 16, 7:31AM CST
NEW YORK, NY / ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc. (NASDAQ: LPCN), Syneron Medical Ltd (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.06 (-0.18), RJET: 1.31 (+0.02), LPCN: 8.16 (-0.94)
Syneron Medical to Participate in Three Investor Conferences in November
PR Newswire - Fri Nov 13, 9:10AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that management is scheduled to participate in three investor conferences in November 2015. The first conference is the Brean Capital 2015 Life Sciences Summit in New York City. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.
ELOS: 7.06 (-0.18)
Syneron Medical elects Jeff Nardoci as president of North America Body Shaping Group
M2 - Thu Nov 12, 3:37AM CST
Aesthetic device company Syneron Medical (NasdaqGS:ELOS) disclosed on Wednesday that it has appointed Jeff Nardoci as president of its North America Body Shaping Group.
ELOS: 7.06 (-0.18)
Syneron Medical reports 3Q loss
Automated Insights - Wed Nov 11, 6:12AM CST
YOKNEAM ILLIT, Israel (AP) _ Syneron Medical Ltd. (ELOS) on Wednesday reported a loss of $6.5 million in its third quarter.
ELOS: 7.06 (-0.18)
Syneron Medical Reports Third Quarter 2015 Revenue of $62.1 Million
PR Newswire - Wed Nov 11, 6:00AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2015.
ELOS: 7.06 (-0.18)
Syneron Candela Announces New FDA Clearance for the CO2RE System
PR Newswire - Thu Nov 05, 8:00AM CST
Expanded FDA Clearance Includes: Gynecology Applications, Wrinkles, Scars, and Numerous Dermatology and Plastic Surgery indications
ELOS: 7.06 (-0.18)
Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
PR Newswire - Thu May 19, 6:00AM CDT
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended March 31, 2016.
ELOS: 7.06 (-0.18)
Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016
PR Newswire - Wed Apr 27, 8:00AM CDT
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, May 19, 2016. The earnings release will be available on Syneron's website at www.investors.syneron.com.
ELOS: 7.06 (-0.18)
Syneron Candela Leads Energy Innovation Discussions at 36th Annual ASLMS Conference
PR Newswire - Thu Mar 31, 8:00AM CDT
Syneron Medical Ltd. (NASDAQ: ELOS) a global leader in aesthetic medical devices, today announced the presentation of 11 scientific abstracts at the Annual Conference of the American Society of Laser Medicine and Surgery (ASLMS). During the conference, industry luminaries will present new and breakthrough findings demonstrating safety and efficacy from clinical studies using Syneron Candela technologies for treating skin pigmentations, removing tattoos, removing hair and restoring vaginal health. The 36th annual conference will take place March 30 through April 3, 2016 at the Sheraton Boston Hotel/Hynes Convention Center in Boston, Mass.
ELOS: 7.06 (-0.18)
Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website
PR Newswire - Mon Mar 21, 3:05PM CDT
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F, containing audited consolidated financial statements for the year ended December 31, 2015, as filed with the Securities and Exchange Commission on March 21, 2016, is available on its website (www.syneron.com). Shareholders may receive a hard copy of the annual report free of charge upon request. This press release is being issued pursuant to NASDAQ Listing Rule 5250(d)(1)(C).
ELOS: 7.06 (-0.18)
Syneron Medical and Allergan Announce U.S. Aesthetics Collaboration
PR Newswire - Sat Mar 05, 1:13PM CST
Syneron Medical Ltd. (NASDAQ: ELOS) a leading global aesthetic device company, and Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, today announced a collaboration to offer three of Syneron Candela's body sculpting and skincare platforms to members of Allergan's healthcare provider loyalty program, Allergan Partner Privileges® (APP®).
AGN: 240.93 (-6.47), ELOS: 7.06 (-0.18)
Global Beauty Devices Market Growth of 18.9% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: L'Oreal Group, Carol Cole Company & Panasonic Corporation
M2 - Fri Feb 05, 8:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/27r9hf/global_beauty) has announced the addition of the "Global Beauty Devices Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type and by Application" report to their offering. The global beauty devices market accounted for $19,716.9 million during 2014, and it is expected to grow with a CAGR of 18.9% during 2015-2020. The Hair removal devices market segment dominated the market during 2014 with about 21.4% share; whereas, among application segment, salon accounted for the highest share of about 55.6% in market during the same year. Beauty devices market is escalating with high growth rate due to growing geriatric population and increasing prevalence of skin diseases as a result of harmful UV radiations. Also, increase in disposable income in developing lead to increased spending on personal care products. Key Topics Covered: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market - Porter analysis identifies competitive forces within the market Companies Mentioned: - Carol Cole Company - Home Skinovations, Ltd - Koninklijke Philips N.V. - L'Oreal Group - Nu Skin Enterprises, Inc. - Panasonic Corporation - PhotoMedex, Inc. - Procter & Gamble Company - Syneron Medical, Ltd. - TRIA Beauty, Inc. Report Structure: 1. Research Scope and Methodology 2. Executive Summary 3. Market Outlook 4. Global Beauty Devices Market Size and Forecast (2011 - 2020) 5. Global Beauty Devices Market Breakdown by Type of Devices 6. Global Beauty Devices Market Breakdown by Application 7. Global Beauty Devices Market Breakdown by Geography 8. Competitive Analysis 9. Company Profiles 10. Appendix For more information visit http://www.researchandmarkets.com/research/27...bal_beauty
ELOS: 7.06 (-0.18), NUS: 41.37 (-0.48), PHMD: 0.23 (-0.02), PG: 83.20 (+0.03)
Syneron Medical to Report Fourth Quarter 2015 and Full Year 2015 Financial Results on February 22, 2016
PR Newswire - Wed Feb 03, 3:01PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2015 and full year 2015 financial results before the market opens on Monday, February 22, 2016. The earnings release will be available on Syneron's website at www.investors.syneron.com.
ELOS: 7.06 (-0.18)
Medical Aesthetics Market Forecast to 2020 - Increasing Demand For Minimally Invasive & Non-Invasive Aesthetic Procedures
M2 - Thu Jan 28, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/bd5l42/medical) has announced the addition of the "Medical Aesthetics Market by Products, Procedures, & End-Users - Global Forecast to 2020" report to their offering. The market is expected to reach $12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020. Factors such as the increasing demand of minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. However, stringent safety regulations for aesthetic procedures, and a significant number of product recalls are restricting the growth of the global medical aesthetics market. Geographically, North America (comprising the U.S. and Canada) commanded the largest share of 49.0% of the global medical aesthetics market in 2015, followed by Europe. North America will continue to lead in the years to come, owing to rapidly aging and obese population, technological advancements, and growing FDA approvals of devices in the U.S. The growth of the global medical aesthetics market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, aging population, increasing awareness among customers, technological advancements in energy-based devices, rising number of aesthetic procedures, and increasing demand for aesthetic treatments among the male population. However, a stringent safety regulation for aesthetic procedures is a major factor restraining the growth of this market. Growing adoption of home use aesthetic devices and increasing demand for cosmetic treatments in emerging markets are creating opportunities for growth of the medical aesthetics market. Companies Mentioned: - Allergan, Inc. - Cynosure, Inc. - Galderma S.A. (Switzerland) - Lumenis Ltd. - Mentor Worldwide LLC - PhotoMedex, Inc. - Solta Medical, Inc. - Syneron Medical, Ltd. - ZELTIQ Aesthetics, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Market, By Product 7 Medical Aesthetics Market, By End User 8 Medical Aesthetics Market, By Procedure 9 Global Medical Aesthetics Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/bd5l42/medical
ELOS: 7.06 (-0.18), AGN: 240.93 (-6.47), ZLTQ: 28.51 (-0.85), CYNO: 51.02 (-1.06), LMNS: 13.76 (+0.04), PHMD: 0.23 (-0.02)
BUYINS.NET: ELOS, PGJ, SMMU, ACW, VIA, MOBI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jan 26, 8:00AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Syneron Medical Ltd (NASDAQ:ELOS), PowerShares Golden Dragon Halter USX China Portfolio (NYSE
GJ), PIMCO Short Term Municipal Bond Strategy Fund (NYSE:SMMU), Accuride Corp (NYSE:ACW), Viacom Inc (NASDAQ:VIA), Sky-mobi Ltd (NASDAQ:MOBI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: ELOS: 7.06 (-0.18), VIA: 46.22 (-2.20), ACW: 1.56 (-0.05), PGJ: 27.84 (-0.74), MOBI: 1.81 (-0.03), VIAB: 42.02 (-2.39), SMMU: 50.53 (+0.14)
Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue
PR Newswire - Mon Jan 11, 3:05PM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today provided preliminary unaudited fourth quarter 2015 revenue results in conjunction with planned meetings January 11-14 surrounding the annual J.P. Morgan Healthcare Conference in San Francisco. Total revenue for the fourth quarter 2015 is expected to be in the range of $78 to $79 million, compared to $74.1 million in the fourth quarter 2014, up approximately 5% to 7% year-over-year, or approximately 9% to 10% in constant currency.
ELOS: 7.06 (-0.18), JPM: 63.84 (-0.91)
Profound Named 2015 Beauty Breakthrough
PR Newswire - Wed Dec 23, 9:22AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, is proud to announce that its revolutionary Profound® non-surgical radiofrequency micro-needle device with proprietary and patent protected technology, has been hailed one of 2015's biggest aesthetic breakthroughs by Yahoo! Beauty and Plastic Surgery Practice Magazine.
ELOS: 7.06 (-0.18)
Dental Lasers Market - Global Forecast to 2020
M2 - Fri Dec 04, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/xckzhj/dental_lasers) has announced the addition of the "Dental Lasers Market - Global Forecast to 2020" report to their offering. The global dental lasers market is expected to reach USD 224.7 million by 2020, at a CAGR of 5.2% during the forecast period from 2015 to 2020. The increasing awareness for oral hygiene; rising middle class and aging population; and rising demand for cosmetic dentistry, reduced treatment time, and operating cost have influenced the growth of the dental lasers market. The soft tissue dental lasers segment accounted for the largest share of the global dental lasers market in 2014. Soft tissue lasers are used to sterilize endodontic canals and treat periodontal disease as well as in tooth whitening procedures. The soft tissue dental laser segment dominated the market, owing to the increased number of cases of gingivectomy and periodontal diseases, among others. North America dominated the dental lasers market, due to the increasing technological advancements, growing awareness with respect to oral hygiene, and rising adoption rate of newer technologies in the region. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, due to factors such as the rise in the awareness of dental lasers, increased number aesthetic procedures, and rise in aging population. Reasons to Buy the Report: From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Industry Trends 5 Market Overview 6 Dental Lasers Market, By Product 7 Dental Lasers Market, By Application 8 Dental Lasers Market, By End User 9 Dental Lasers Market, By Geography 10 Competitive Landscape 11 Company Profiles - AMD Lasers - Biolase, Inc. - CAO Group, Inc. - Convergent Dental, Inc. - Danaher Corporation- Kavo Dental Gmbh - Fotona D.D. - Ivoclar Vivadent AG - Millennium Dental Technologies, Inc. - Sirona Dental Systems, Inc. - Syneron Dental Lasers-Syneron Medical Ltd. - The Yoshida Dental Mfg. Co., Ltd. - Zolar Technology & Mfg. Co. Inc. For more information visit http://www.researchandmarkets.com/research/xc...tal_lasers
ELOS: 7.06 (-0.18), SIRO: 109.97 (-0.13), BIOL: 1.22 (+0.05), DHR: 99.31 (-1.08)
Syneron to Host 2015 Analyst Day on December 3, 2015
PR Newswire - Tue Dec 01, 8:00AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an Analyst Day meeting on Thursday, December 3, 2015 from 8:30 am to 11:30 am ET (registration begins at 8:30 am, formal presentation begins at 9:00 am). The meeting will include a review of the Company's key growth platforms, including UltraShape, PicoWay, and Profound and will feature presentations from management and clinician key opinion leaders.
ELOS: 7.06 (-0.18)
Analyst Insights behind Price Movement - Research on Lipocine, Syneron Medical, Republic Airways and Accretive Health
ACCESSWIRE - Tue Nov 24, 7:32AM CST
NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc (NASDAQ: LPCN), Syneron Medical Ltd. (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health, Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.06 (-0.18), RJET: 1.31 (+0.02), LPCN: 8.16 (-0.94)
Origins of Technical Movement, Pricing Tomorrow - Research on Lipocine, Syneron Medical, Republic Airways Holdings, and Accretive Health
ACCESSWIRE - Mon Nov 16, 7:31AM CST
NEW YORK, NY / ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc. (NASDAQ: LPCN), Syneron Medical Ltd (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.06 (-0.18), RJET: 1.31 (+0.02), LPCN: 8.16 (-0.94)
Syneron Medical to Participate in Three Investor Conferences in November
PR Newswire - Fri Nov 13, 9:10AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that management is scheduled to participate in three investor conferences in November 2015. The first conference is the Brean Capital 2015 Life Sciences Summit in New York City. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.
ELOS: 7.06 (-0.18)
Syneron Medical elects Jeff Nardoci as president of North America Body Shaping Group
M2 - Thu Nov 12, 3:37AM CST
Aesthetic device company Syneron Medical (NasdaqGS:ELOS) disclosed on Wednesday that it has appointed Jeff Nardoci as president of its North America Body Shaping Group.
ELOS: 7.06 (-0.18)
Syneron Medical reports 3Q loss
Automated Insights - Wed Nov 11, 6:12AM CST
YOKNEAM ILLIT, Israel (AP) _ Syneron Medical Ltd. (ELOS) on Wednesday reported a loss of $6.5 million in its third quarter.
ELOS: 7.06 (-0.18)
Syneron Medical Reports Third Quarter 2015 Revenue of $62.1 Million
PR Newswire - Wed Nov 11, 6:00AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2015.
ELOS: 7.06 (-0.18)
Syneron Candela Announces New FDA Clearance for the CO2RE System
PR Newswire - Thu Nov 05, 8:00AM CST
Expanded FDA Clearance Includes: Gynecology Applications, Wrinkles, Scars, and Numerous Dermatology and Plastic Surgery indications
ELOS: 7.06 (-0.18)
